InnovAge (INNV) Expected to Announce Earnings on Tuesday

InnovAge (NASDAQ:INNV) is projected to release its Q1 2027 results after the market closes on Tuesday, November 3rd. Analysts expect InnovAge to post earnings of $0.0859 per share and revenue of $257.23 million for the quarter. Individuals can check the company’s upcoming Q1 2027 earnings summary page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 5:00 PM ET.

InnovAge (NASDAQ:INNV) last issued its earnings results on Tuesday, September 8th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.01). InnovAge had a negative net margin of 0.26% and a negative return on equity of 1.03%. The firm had revenue of $261.95 million during the quarter, compared to analysts’ expectations of $238.33 million. On average, analysts expect InnovAge to post $0.43 EPS for the current fiscal year and $0.48 EPS for the next fiscal year.

InnovAge Stock Down 2.9%

InnovAge stock opened at $9.27 on Tuesday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.05 and a quick ratio of 1.05. InnovAge has a 1-year low of $3.93 and a 1-year high of $12.64. The stock’s 50 day moving average price is $9.97 and its 200 day moving average price is $8.96. The company has a market cap of $1.26 billion, a PE ratio of -463.50 and a beta of 0.15.

Wall Street Analysts Forecast Growth

INNV has been the topic of a number of research reports. KeyCorp upped their price target on InnovAge from $13.00 to $14.00 and gave the stock an “overweight” rating in a report on Wednesday, September 9th. Wall Street Zen lowered shares of InnovAge from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 18th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of InnovAge in a report on Thursday, August 13th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $10.50.

Insider Activity at InnovAge

In related news, insider Nicole Damato sold 3,402 shares of the business’s stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $9.51, for a total transaction of $32,353.02. Following the completion of the sale, the insider owned 301,495 shares of the company’s stock, valued at $2,867,217.45. This represents a 1.12% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Aggregator Lp Ignite sold 1,500,000 shares of the stock in a transaction that occurred on Wednesday, October 21st. The stock was sold at an average price of $9.25, for a total value of $13,875,000.00. Following the sale, the insider owned 101,076,555 shares in the company, valued at $934,958,133.75. The trade was a 1.46% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 13,027,216 shares of company stock valued at $120,489,535 over the last three months. 1.00% of the stock is owned by insiders.

InnovAge Company Profile

InnovAge (NASDAQ: INNV) is a healthcare services company that provides comprehensive care for older adults through the Program of All-Inclusive Care for the Elderly (PACE). Its model is designed to help eligible seniors remain living in their homes and communities rather than moving to nursing facilities, while coordinating medical, social, and supportive services through an integrated care program.

InnovAge’s services may include primary and specialty medical care, nursing, physical and occupational therapy, behavioral health, pharmacy services, dentistry, vision care, meals, transportation, social services, and in-home support.